Skip to main content
. 2016 Sep;16(3):734–743. doi: 10.4314/ahs.v16i3.13

Table 2.

Anticancer (LC50 in µg/mL) of compounds from 1–6 and their selectivity index (SI).

Compounds Cytotoxicty (LC50 in µg/mL) Selectivity Index*

HeLa cells Vero cells HeLa
cells
V.
cholerae
SG24 (1)
V.
cholerae
CO6
V.
cholerae
NB2
V.
cholerae
PC2
S.
flexneri
SDINT
1 6.33 ± 0.66a 124.72 ± 1.27a 19.70 15.59 7.79 3.89 3.89 7.79
2 6.74 ± 0.27a 158.24 ± 2.86b 23.47 39.56 4.94 9.89 19.78 9.89
3 8.13 ± 0.18b 233.26 ± 3.73c 28.69 466.52 14.57 29.15 466.52 29.15
4 9.21 ± 0.79b 261.14 ± 2.87d 28.35 4.08 2.04 2.04 2.04 4.08
5 2.06 ± 0.23c 195.41 ± 1.79e 94.85 3.05 3.05 6.10 6.10 6.10
6 0.88 ± 0.12d 277.62 ± 1.38f 315.47 4.33 2.16 4.33 2.16 2.16
Paclitaxel 0.57 ± 0.03e 68.51 ± 0.19g 120.19 / / / / /

/: not determined, SI = LC50 on Vero cells /MIC or LC50 on HeLa cells;

*

SI obtained from average MIC. Each LC50 value represents the mean ± SD (n = 3). In the same column, LC50 values marked with different superscript letters (a-g) are significantly different (p < 0.05).